- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/21 - Interferons
Patent holdings for IPC class A61K 38/21
Total number of patents in this class: 2275
10-year publication summary
|
190
|
172
|
177
|
151
|
166
|
228
|
172
|
163
|
102
|
40
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19681 |
33 |
| IBC Pharmaceuticals, Inc. | 93 |
31 |
| Centre National de La Recherche Scientifique | 10202 |
25 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
21 |
| Modernatx, Inc. | 1249 |
21 |
| Iovance Biotherapeutics, Inc. | 334 |
21 |
| Bristol-myers Squibb Company | 4848 |
20 |
| Gilead Sciences, Inc. | 2009 |
20 |
| Biogen MA Inc. | 885 |
19 |
| ILC Therapeutics Ltd | 27 |
18 |
| ellennbe GmbH | 24 |
18 |
| Vib VZW | 853 |
17 |
| Toray Industries, Inc. | 6840 |
16 |
| Universiteit Gent | 1324 |
16 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3093 |
16 |
| Enanta Pharmaceuticals, Inc. | 431 |
15 |
| Mayo Foundation for Medical Education and Research | 3146 |
14 |
| F. Hoffmann-La Roche AG | 7889 |
13 |
| Teva Pharmaceuticals Australia Pty Ltd | 30 |
13 |
| Enyo Pharma | 57 |
13 |
| Other owners | 1895 |